Related Experiment Videos
In vitro elution of vancomycin from biodegradable beads
1Department of Mechanical Engineering, Chang Gung University, Tao-Yuan 333, Taiwan, ROC. shihjung@mail.cgu.edu.tw
Journal of Biomedical Materials Research
|September 22, 1999
Summary
Biodegradable polymers offer a promising alternative to non-degradable polymethylmethacrylate (PMMA) beads for antibiotic delivery in orthopedic infections. These novel beads provide sustained drug release for effective treatment, potentially eliminating the need for removal surgery.
Area of Science:
- Biomaterials Science
- Orthopedic Surgery
- Infectious Diseases
Background:
- Current antibiotic delivery for orthopedic infections relies on polymethylmethacrylate (PMMA) beads, which are non-biodegradable and require surgical removal.
- This necessitates a secondary operation, increasing patient burden and healthcare costs.
Purpose of the Study:
- To investigate the use of biodegradable polymers as antibiotic-eluting beads for long-term drug delivery in orthopedic infections.
- To evaluate the effect of processing parameters on antibiotic release rates and efficacy.
Main Methods:
- Polylactide-polyglycolide copolymers were mixed with vancomycin and processed into beads.
- Bead size and processing parameters were varied.
- In vitro elution studies were conducted over 35 days at 37°C to measure antibiotic release.
- Bacterial inhibition tests assessed the antimicrobial activity of released vancomycin.
Main Results:
- Biodegradable beads released high concentrations of vancomycin in vitro for 4-6 weeks, exceeding the minimum inhibitory concentration.
- Antibiotic release rates were controllable by adjusting processing parameters.
- Bacterial inhibition zones ranged from 6.5-10 mm, indicating significant antimicrobial activity (12.5-100% relative activity).
Conclusions:
- Biodegradable polymer beads offer a viable alternative for sustained antibiotic delivery in orthopedic infections.
- Tunable processing parameters allow for customized drug release profiles to meet specific patient needs.
- This approach may reduce the need for repeat surgeries associated with non-biodegradable implants.